News & Updates

Use of therapeutic heparin does not appear to significantly reduce the death, mechanical ventilation, or intensive care unit (ICU) admission in hospitalized patients with moderate COVID-19 and increased D-dimer levels, reveals a study. However, it is associated with a significantly lower chances of all-cause death and reduced risk of major bleeding.

In a systematic review and meta-analysis, glycaemic parameters in patients with type 1 diabetes (T1D) improved during the COVID-19 lockdown periods. Conversely, patients with type 2 diabetes (T2D) had short-term worsening of glycaemic values.

Reopening workplaces and establishments after the lifting of coronavirus disease 2019 (COVID-19) lockdowns leads to an increase in physical activity as well as notable shifts in sleep patterns and mental wellbeing, according to a recent Singapore study.

That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.

Survivors of bacterial meningitis (BM) suffer from an impaired health-related quality of life (HRQOL), regardless of possible disability, a study using parents’ perceptions has concluded.

Treatment with corticosteroids (CS) among children with multisystem inflammatory syndrome (MIS-C) cardiovascular involvement temporarily associated with COVID-19 leads to faster normalization of left ventricular ejection fraction (LVEF), fever, improved laboratory analysis, and shorter intensive care unit stay than treatment with intravenous immunoglobulin (IVIG), a study has shown.